Choose a section
Unilife Corp. has entered a deal with Hikma to launch 20 generic injectable drugs using Unilife's pre-filled syringe technology, the two companies said Wednesday.
Gov. Sam Brownback of Kansas attended the grand opening of a new pharmacy hub that will serve post-acute patients in and around the state.
Use of injectable drugs for multiple sclerosis declined during the 12-month period that ended on June 30 as orally administered drugs for the condition became more popular, according to a new report.
Global spending on drugs will pass the $1 trillion mark next year, according to a new study by the IMS Institute for Healthcare Informatics, a division of healthcare market analysis firm IMS Health.
A bill that would implement federal tracking and tracing of drugs and strengthen federal regulations on pharmacy compounding has passed in the Senate and will go to President Barack Obama for his signature.
Drug maker Actavis hopes to become the first to market with a generic version of a topical testosterone replacement drug marketed by Eli Lilly, Actavis said.
Drug maker Upsher-Smith Labs will present data from a late-stage trial of a drug for treating epilepsy, the company said Monday.
URAC has granted accreditation to Parkway Pharmacy, a specialty pharmacy based in New Jersey.
The global market for biosimilars is expected to be worth nearly $2 billion before the end of the decade, according to a new study.
Generic drug maker Mylan has launched its version of a drug for treating attention deficit hyperactivity disorder, the company said Monday.